<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The concurrent occurrence of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and <z:hpo ids='HP_0000873'>diabetes insipidus</z:hpo> is very rare </plain></SENT>
<SENT sid="1" pm="."><plain>In the available literature so far only three cases were described </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> the concurrence of the two diseases is rare </plain></SENT>
<SENT sid="3" pm="."><plain>The authors describe two cases of concurrent <z:hpo ids='HP_0000873'>diabetes insipidus</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> with typical clinical and laboratory symptoms </plain></SENT>
<SENT sid="4" pm="."><plain>A 27-year-old man with refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (according to the FAB classification of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>) died after 10 months from complications of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>In a 58-year-old female patients with refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> after two years remission the condition deteriorated and developed into RASEB (refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess of blast cells) according to the FAB classification with partial remission of the disease after <z:chebi fb="0" ids="35610">cytostatic</z:chebi> treatment </plain></SENT>
<SENT sid="6" pm="."><plain>During permanent substitution treatment (Adiuretin Spofa) <z:hpo ids='HP_0000873'>diabetes insipidus</z:hpo> was compensated in both diseases </plain></SENT>
</text></document>